Credit and Corporate Debt: Latest News, Top Stories & Analysis

Mineralys Restructures Drug Economics With $500 Million Financing

June 9, 2026June 8, 2026 - by Timothy Alexander

RADNOR, PA — Mineralys Therapeutics (NASDAQ: MLYS) has agreed to eliminate future royalty obligations tied to its lead drug candidate lorundrostat while securing access to up to $500 million in …

Regional

Madrigal Pharmaceuticals Secures $500 Million Credit Facility to Expand MASH Pipeline

July 23, 2025July 22, 2025 - by Timothy Alexander

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has secured a $500 million senior secured credit facility from funds managed by Blue Owl Capital (NYSE: OWL), strengthening its financial position …